BOOT vs TSLA

BOOT exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust accounting strength, though the absence of an Altman Z-Score limits distress risk assessment. The company shows impressive profitability and growth, with 18.7% YoY revenue growth and 44.2% earnings growth, supported by strong margins and solid ROE of 18.74%. However, elevated valuation metrics, insider selling, and weakening near-term earnings momentum contrast with bullish analyst sentiment and strong long-term price performance. The stock trades above the Graham Number of $76.71 and below the growth-based intrinsic value of $195.29, suggesting a fair-to-slightly-rich valuation.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.